Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Immunotherapy

NEIL CANAVAN
A new book delves into the stories of 25 immunotherapy pioneers and the history of the field they helped to develop.
LAURIE TOICH
Immunotherapy’s effectiveness may depend on the bacteria living in patients’ gastrointestinal tracts, studies show.
WAYNE KUZNAR
Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.
Gregory L. Beatty, M.D., Ph.D.
The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.
MIKE HENNESSY, SR.
Immunotherapy revolutionized the way we treat cancer. And now, researchers are using drugs to help jumpstart the immune system alongside chemotherapy to keep treatment moving forward.
 
Brielle Urciuoli
Sometimes patients may not report side effects to their health care team, in fear of their oncologist taking them off a drug that could prolong their survival.
Kristie L. Kahl
After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.
Jarushka Naidoo, MBBCh
Immunotherapy use continues to expand in the cancer treatment space. So, it is important that patients and caregivers understand its potential side effects.
Brielle Urciuoli
Recently, the Cancer Support Community (CSC) conducted a survey to better grasp the challenges that patients, caregivers and clinical staff members face regarding immunotherapy. The goal is to ultimately use that information to craft an empowerment program that will improve the patient experience.
Ghassan K. Abou-Alfa, MD, shares his excitement over the use of immunotherapy for liver cancer in 2018, and highlights research initiatives that are studying its potential in combination with other therapies.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other